Indivior Pharmaceuticals (INDV) Receivables - Net (2021 - 2025)
Indivior Pharmaceuticals (INDV) has 5 years of Receivables - Net data on record, last reported at $253.0 million in Q4 2025.
- For Q4 2025, Receivables - Net changed 0.39% year-over-year to $253.0 million; the TTM value through Dec 2025 reached $253.0 million, changed 0.39%, while the annual FY2025 figure was $253.0 million, 0.39% changed from the prior year.
- Receivables - Net reached $253.0 million in Q4 2025 per INDV's latest filing, down from $259.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $259.0 million in Q3 2025 and bottomed at $202.0 million in Q4 2021.
- Average Receivables - Net over 5 years is $240.6 million, with a median of $248.0 million recorded in 2025.
- Peak YoY movement for Receivables - Net: increased 15.45% in 2023, then dropped 0.39% in 2025.
- A 5-year view of Receivables - Net shows it stood at $202.0 million in 2021, then increased by 8.91% to $220.0 million in 2022, then rose by 15.45% to $254.0 million in 2023, then changed by 0.0% to $254.0 million in 2024, then dropped by 0.39% to $253.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $253.0 million in Q4 2025, $259.0 million in Q3 2025, and $240.0 million in Q2 2025.